Drug Initiative

Is the FDA ignoring heart risks from high triglycerides in the face of mounting evidence to the contrary?

The lives of millions of Americans are potentially at risk.

The EPA Drug Initiative (EPADI) urges the FDA to thoughtfully consider new and almost irrefutable proof that high triglycerides are a significant risk factor contributing to cardiovascular disease-related death and morbidity.

Recently, two independent studies were published in the prestigious New England Journal of Medicine (NEJM), both drawing the same conclusion: that reducing serum triglycerides to accepted, safe levels resulted in a 40% decrease in cardiovascular risk. These trial results are being universally hailed as groundbreaking, as they focus on people having a certain gene mutation, which elegantly eliminates all cardiovascular disease risk factors other than serum triglyceride levels. Both studies—from well-respected researchers—have caught the attention of the world, with the results being published by prominent news media including the New York Times and Forbes.

Read the Full Story

Since taking V my HT have dropped significantly as well as my LDL's. Also my arthritis is so much better I no longer have to consume large amounts of Tylenol..damaging my Liver or Ibuprofen which can cause stomach problems if taken in on a regular basis...this wonderful, NATURAL based product has saved me from a lot of discomfort , improved my life, illuminated unnecessary RX that have bad side effects ,creating even more problems with the need for even more RX because of the side effects...How could you not approve this for the general population!!! Everything to gain and nothing to lose..please reconsider

Ron Squires
Ortonville, MI
Back To Top